PZPPF wants longer transitory period for drugs

In this way, PZPPF is not only attempting to save its own finances but also those of the state budget and patients. "All new drugs registered after the country joins the EU and through to 2006 will be protected for six years. A ten year long protection period will apply to new drugs registered after 2006. During these periods, domestic companies will not be able to produce generic medicines," explains Cezary Śledziewski, the head of PZPPF. The Union would like to see the introduction of this regulation postponed until 2011. According to PZPPF, the limitations are only beneficial for innovative pharmaceutical companies, which simply do not exist in Poland. (Puls Biznesu, pp. 1, 4) A.K.